United Therapeutics (UTHR) Interest & Investment Income (2017 - 2025)
Historic Interest & Investment Income for United Therapeutics (UTHR) over the last 15 years, with Q3 2025 value amounting to $46.4 million.
- United Therapeutics' Interest & Investment Income fell 682.73% to $46.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.1 million, marking a year-over-year decrease of 134.46%. This contributed to the annual value of $199.1 million for FY2024, which is 2237.25% up from last year.
- United Therapeutics' Interest & Investment Income amounted to $46.4 million in Q3 2025, which was down 682.73% from $51.3 million recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Interest & Investment Income ranged from a high of $53.8 million in Q1 2024 and a low of $3.8 million during Q3 2021
- In the last 5 years, United Therapeutics' Interest & Investment Income had a median value of $37.2 million in 2023 and averaged $30.1 million.
- Per our database at Business Quant, United Therapeutics' Interest & Investment Income plummeted by 5300.0% in 2021 and then soared by 57906.98% in 2023.
- Quarter analysis of 5 years shows United Therapeutics' Interest & Investment Income stood at $4.2 million in 2021, then skyrocketed by 395.24% to $20.8 million in 2022, then skyrocketed by 145.19% to $51.0 million in 2023, then fell by 3.33% to $49.3 million in 2024, then fell by 5.88% to $46.4 million in 2025.
- Its Interest & Investment Income stands at $46.4 million for Q3 2025, versus $51.3 million for Q2 2025 and $51.1 million for Q1 2025.